Cargando…

Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease

OBJECTIVE: Reduced exercise capacity is well documented in end-stage chronic kidney disease (CKD), preceded by changes in cardiac morphology in CKD stage 3. However, it is unknown whether subclinical cardiopulmonary dysfunction occurs in CKD stage 3 independently of heart failure. METHODS: Prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nelson, Alexander, Otto, James, Whittle, John, Stephens, Robert C M, Martin, Daniel S, Prowle, John R, Ackland, Gareth L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847133/ https://www.ncbi.nlm.nih.gov/pubmed/27127638 http://dx.doi.org/10.1136/openhrt-2015-000370

Ejemplares similares

Sympathetic autonomic dysfunction and impaired cardiovascular performance in higher risk surgical patients: implications for perioperative sympatholysis
por: Whittle, John, et al.
Publicado: (2015)

Heavy alcohol drinking and subclinical echocardiographic abnormalities of structure and function
por: Iakunchykova, Olena, et al.
Publicado: (2021)

Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study
por: Tomas, Cara, et al.
Publicado: (2017)

Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
por: Zahir, Hamim, et al.
Publicado: (2022)

Investigation of early signs of systolic and diastolic dysfunction among persons with type 1 diabetes
por: Vestberg, Daniel, et al.
Publicado: (2019)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End‐Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy Subjects
por: Dymond, Angela W., et al.
Publicado: (2016)

Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study
por: Newton, Julia L, et al.
Publicado: (2016)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

Pharmacokinetics of serelaxin in patients with severe renal impairment or end‐stage renal disease requiring hemodialysis: A single‐dose, open‐label, parallel‐group study
por: Dahlke, Marion, et al.
Publicado: (2015)

Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2015)

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry
por: Apenteng, Patricia, et al.
Publicado: (2023)

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
por: Brucato, Antonio, et al.
Publicado: (2023)

Risk of cardiac manifestations in adult mitochondrial disease caused by nuclear genetic defects
por: Lim, Albert Zishen, et al.
Publicado: (2021)

Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
por: Niederdöckl, Jan, et al.
Publicado: (2019)

Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment
por: Gibbs, John P., et al.
Publicado: (2016)

Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations
por: Bourke, John, et al.
Publicado: (2022)

Protective lipid-lowering variants in healthy older individuals without coronary heart disease
por: Lacaze, Paul, et al.
Publicado: (2021)

A prognostic scoring system for arm exercise stress testing
por: Xie, Yan, et al.
Publicado: (2016)

Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study
por: Nikiphorou, Elena, et al.
Publicado: (2020)

Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
por: Wang, Ellen Q., et al.
Publicado: (2021)

Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
por: Wang, Ellen Q., et al.
Publicado: (2022)

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
por: Hoos, Anton, et al.
Publicado: (2015)

Cardiovascular disease in HIV patients: from bench to bedside and backwards
por: Cerrato, Enrico, et al.
Publicado: (2015)

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy
por: Hodes, Anke R, et al.
Publicado: (2016)

Postoperative goal-directed therapy and development of acute kidney injury following major elective noncardiac surgery: post-hoc analysis of POM-O randomized controlled trial
por: Patel, Amour, et al.
Publicado: (2017)

Access to Medicaid and Medicare by the low-income disabled
por: Ellwood, Marilyn Rymer, et al.
Publicado: (1990)

Medicaid-financed residential care for persons with mental retardation
por: Lakin, K. Charlie, et al.
Publicado: (1990)

Medicaid mysteries: Transitional benefits, Medicaid coverage, and welfare exits
por: Ellwood, David T., et al.
Publicado: (1990)

Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis
por: Gaze, David C, et al.
Publicado: (2014)

Heart rate variability analysis during head-up tilt test predicts nitroglycerine-induced syncope
por: Efremov, Kristian, et al.
Publicado: (2014)

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment
por: Torres, Rosarelis, et al.
Publicado: (2015)

Subtle increases in heart size persist into adulthood in growth restricted babies: the Cardiovascular Risk in Young Finns Study
por: Arnott, Clare, et al.
Publicado: (2015)

Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension
por: Stott, D, et al.
Publicado: (2016)

Effects of paediatric HIV infection on electrical conduction of the heart
por: Idris, Nikmah S, et al.
Publicado: (2016)

Pharmacokinetics, Pharmacodynamics, and Safety of Peginterferon Beta-Ia in Subjects with Normal or Impaired Renal Function
por: Hu, Xiao, et al.
Publicado: (2015)

Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
por: He, Ping, et al.
Publicado: (2014)

Improvements in ECG accuracy for diagnosis of left ventricular hypertrophy in obesity
por: Rider, Oliver J, et al.
Publicado: (2016)

Genetics of inherited cardiocutaneous syndromes: a review
por: Bardawil, Tara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eb7ohc93ct9dcuj6nv59lgi22d